Skip to content

Munich Business Plan Competition Winner Announced: Bioexotec Emerges Victorious

In the Munich Business Plan Competition 2025, BioExotec takes the top spot, showcasing a groundbreaking innovation for early cancer detection.

Munich-based firm, Bioexotec, emerges victorious in the local business plan competition
Munich-based firm, Bioexotec, emerges victorious in the local business plan competition

Munich Business Plan Competition Winner Announced: Bioexotec Emerges Victorious

In the heart of Munich, the annual Business Plan Competition has once again proven to be a platform for groundbreaking ideas and promising startups. This year, the competition, organised by Baystartup, attracted over 241 participants from Munich and Southern Bavaria, with many teams hailing directly from the scientific community.

Among the finalists, we find a diverse array of innovators, each tackling unique challenges in their respective fields.

Ovlay, a specialist in automated 3D modeling from images, showcases its potential in revolutionising design processes. Bioexotec, a spin-off of the TUM Clinic right of the Isar, secured first place with its non-invasive blood and saliva test that can detect certain types of cancer at an early stage. This life-saving technology could significantly improve the chances of successful treatment for countless patients.

Peak Quantum, a spin-off of the Walther-Meißner-Institute, impressed the judges with its work on robust processors for quantum computers. The new architecture of their Quantum Processing Units (QPUs) is designed to offer a tenfold higher reliability than existing models, paving the way for a more stable and efficient quantum computing future.

Versatile Robotics, a robotics startup spun off from the German Aerospace Center (DLR), took third place with its development of intelligent control software that enables robots to perform complex and delicate tasks. This technology could revolutionise industries reliant on precision and automation.

Other finalists include Linque, developing photonic chips, Agentix, offering AI automation without the need for programming knowledge, and Onyx, providing simulation software for drug development.

The competition, endowed with 48,500 euros and consisting of three phases, underscores the importance of nurturing innovation and supporting startups. Max Achmedschin, head of the competition at Baystartup, emphasises the convergence of knowledge, capital, and researcher interest in starting companies. He highlights the key to success as understanding business economic contexts, detail-oriented thinking, and clear presentation of one's vision.

Baystartup continues to support the teams after the finale, offering coaching and access to investors. With more than 300 volunteer jurors involved in the evaluation, the competition ensures a fair and comprehensive assessment of each startup's potential.

The strong focus on Deeptech and hardware solutions in the competition reflects the growing importance of these fields in driving technological advancements. As these startups continue to develop and grow, we can look forward to a future filled with innovation and progress.

  • Ovlay's automated 3D modeling technology, demonstrating its potential to revolutionize design processes, showcases an intersection of science and business.
  • Bioexotec's non-invasive blood and saliva test, designed to detect certain types of cancer at an early stage, highlights the role of health-and-wellness in both science and business.
  • Peak Quantum's work on robust processors for quantum computers, impressing judges with its promise of a tenfold higher reliability than existing models, underscores the significance of science, technology, and finance in driving the future of business.

Read also:

    Latest